Search Results - "Pizcueta, Pilar"
-
1
A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma
Published in Cancer cell (13-07-2010)“…We have unveiled a synthetic lethal interaction between K- Ras oncogenes and Cdk4 in a mouse tumor model that closely recapitulates human non-small cell lung…”
Get full text
Journal Article -
2
Development of PPARγ Agonists for the Treatment of Neuroinflammatory and Neurodegenerative Diseases: Leriglitazone as a Promising Candidate
Published in International journal of molecular sciences (01-02-2023)“…Increasing evidence suggests that the peroxisome proliferator-activated receptor γ (PPARγ), a member of the nuclear receptor superfamily, plays an important…”
Get full text
Journal Article -
3
PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia
Published in Neurobiology of disease (01-01-2021)“…Friedreich ataxia (FRDA), the most common autosomal recessive ataxia, is characterized by degeneration of the large sensory neurons and spinocerebellar tracts,…”
Get full text
Journal Article -
4
Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models
Published in Nature communications (04-09-2024)“…Mutations in mitochondrial energy-producing genes lead to a heterogeneous group of untreatable disorders known as primary mitochondrial diseases (MD). Leigh…”
Get full text
Journal Article -
5
Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome
Published in Journal of translational medicine (26-10-2023)“…Abstract Background Rett syndrome is a neuropediatric disease occurring due to mutations in MECP2 and characterized by a regression in the neuronal development…”
Get full text
Journal Article -
6
Clinical pharmacokinetics of leriglitazone and a translational approach using PBPK modeling to guide the selection of the starting dose in children
Published in CPT: pharmacometrics and systems pharmacology (01-06-2024)“…Leriglitazone is a unique peroxisome proliferator‐activated receptor‐gamma (PPARγ) agonist that crosses the blood–brain barrier in humans and clinical trials…”
Get full text
Journal Article -
7
PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes
Published in Pharmaceutics (06-01-2023)“…The novel brain-penetrant peroxisome proliferator-activated receptor gamma agonist leriglitazone, previously validated for other rare neurodegenerative…”
Get full text
Journal Article -
8
Distinct synovial immunopathology in Behçet disease and psoriatic arthritis
Published in Arthritis research & therapy (01-01-2009)“…The aim of the study was to investigate synovial immunopathology differences between early Behçet disease (BD) and psoriatic arthritis (PsA). Needle…”
Get full text
Journal Article -
9
Identification and Functional Characterization of the Hepatic Stellate Cell CD38 Cell Surface Molecule
Published in The American journal of pathology (2007)“…The activation of hepatic stellate cells (HSCs) is a critical event in hepatic fibrosis, because these cells are the main producers of extracellular matrix…”
Get full text
Journal Article -
10
Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition
Published in Gastroenterology (New York, N.Y. 1943) (01-12-1992)“…The effects of NG-monomethyl-L-arginine (L-NMMA), an inhibitor of nitric oxide (NO) biosynthesis on the splanchnic and systemic circulation, were investigated…”
Get more information
Journal Article -
11
Platelets activated by transient coronary occlusion exacerbate ischemia-reperfusion injury in rat hearts
Published in American journal of physiology. Heart and circulatory physiology (01-09-2002)“…Platelets (Plt) accumulate in reperfused myocardium but their effect on myocardial necrosis has not been established. We tested the hypothesis that the effect…”
Get more information
Journal Article -
12
Concanavalin-A-induced liver injury is severely impaired in mice deficient in P-selectin
Published in Journal of leukocyte biology (01-08-2002)“…P‐selectin (CD62P) is an adhesion molecule that mediates the initial attachment of leukocytes to activated platelets and endothelial cells in damaged tissues…”
Get full text
Journal Article -
13
Enhanced monocyte activation and hepatotoxicity in response to endotoxin in portal hypertension
Published in Journal of hepatology (2000)“…Background/Aims: Septic shock is a systemic response to infection, and it causes a high mortality rate in cirrhotic patients. The mechanisms responsible for…”
Get full text
Journal Article -
14
The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy
Published in Science translational medicine (02-06-2021)“…X-linked adrenoleukodystrophy (X-ALD), a potentially fatal neurometabolic disorder with no effective pharmacological treatment, is characterized by clinical…”
Get more information
Journal Article -
15
MIN102 (Leriglitazone), a Brain Penetrant PPAR Gamma Agonist for the Treatment of Friedreich’s Ataxia (4147)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
16
A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effects on Biomarkers of MIN-102 (Leriglitazone) (4149)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
17
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial
Published in Lancet neurology (01-02-2023)“…Adult patients with adrenoleukodystrophy have a poor prognosis owing to development of adrenomyeloneuropathy. Additionally, a large proportion of patients with…”
Get full text
Journal Article -
18
MIN-102 (leriglitazone), a Brain Penetrant PPAR gamma Agonist, Decreases Neuroinflammation and Neurodegeneration and Promotes Re-Myelination in Preclinical Models of X-linked Adrenoleukodystrophy (X-ALD) (759)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
19
Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting
Published in Hepatology (Baltimore, Md.) (01-06-1989)“…The present study investigated whether, in rats with portal hypertension due to cirrhosis of the liver induced by carbon tetrachloride, blood volume…”
Get more information
Journal Article -
20
Hemodynamic effects of glucagon in portal hypertension
Published in Hepatology (Baltimore, Md.) (01-04-1990)“…It has been suggested that glucagon contributes to the pathogenesis of portal hypertension by increasing portal blood flow. This study examined this issue by…”
Get more information
Journal Article